For the year ending 2025-12-31, AQST has $160,425K in assets. $194,087K in debts.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 121,169 | |||
| Trade and other receivables, net | 17,763 | |||
| Inventories, net | 6,169 | |||
| Prepaid expenses and other current assets | 4,168 | |||
| Total current assets | 149,269 | |||
| Property and equipment, net | 3,893 | |||
| Right-of-use assets, net | 4,621 | |||
| Other non-current assets | 2,642 | |||
| Total assets | 160,425 | |||
| Accounts payable | 29,862 | |||
| Accrued expenses | 5,029 | |||
| Lease liabilities, current | 631 | |||
| Deferred revenue, current | 1,092 | |||
| Liability related to the sale of future revenue, current | 1,000 | |||
| Royalty obligations, current | 0 | |||
| Loans payable, current | 9,994 | |||
| Total current liabilities | 47,608 | |||
| Notes payable, net | 27,519 | |||
| Royalty obligations, net | 25,941 | |||
| Liability related to the sale of future revenue, net | 62,023 | |||
| Lease liabilities | 4,337 | |||
| Deferred revenue, net of current portion | 19,390 | |||
| Other non-current liabilities | 7,269 | |||
| Total liabilities | 194,087 | |||
| Common stock, 0.001 par value. authorized 250,000,000 shares 122,044,299 and 91,413,742 shares issued and outstanding at december 31, 2025 and december 31, 2024, respectively | 122 | |||
| Additional paid-in capital | 413,214 | |||
| Accumulated deficit | -446,998 | |||
| Total stockholders deficit | -33,662 | |||
| Total liabilities and stockholders deficit | 160,425 | |||
Aquestive Therapeutics, Inc. (AQST)
Aquestive Therapeutics, Inc. (AQST)